Allt inom Report
Nanexa publishes interim report for January-June 2024
NEX-22 clinical trial initiated and proceeding with dose escalation as planned
Nanexa publishes interim report for January-March 2024
NEX-22 clinical trial preparations ongoing and Novo Nordisk collaboration progressing well